Watrium has entered into an agreement to sell sections in Fondsbygget at Aker Brygge in Oslo to Norwegian Property. The sections comprise approximately 3,200 square meters, mainly retail space on...
19th August 2016
Watrium invests to become a shareholder of Ultimovacs, a pharmaceutical company developing novel immunotherapy against cancer. Its leading product is UV1, a therapeutic cancer vaccine directed against human telomerase. Watrium’s...
28th October 2015
Watrium invests in a 20 percent ownership share in Fornebu Gateway AS, which owns two ultra-modern office buildings at Fornebu outside Oslo. The buildings have lease contract durations of around...
